An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: a case report

TitleAn unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: a case report
Publication TypeJournal Article
Year of Publication2006
AuthorsGupta S, Jain A, Fanning TV, Couriel DR, Jimenez CA, Eapen GA
JournalBMC cancer
Volume6
Pagination87
Date Published39173
ISSN1471-2407; 1471-2407
Accession NumberPMID: 16603072; 1471-2407-6-87 [pii]
KeywordsAnimals, Anti-Infective Agents / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Combined Modality Therapy, Fatal Outcome, Hematopoietic Stem Cell Transplantation, Hemorrhage / etiology, Humans, Immunocompromised Host, Ivermectin / therapeutic use, Klebsiella Infections / complications / drug therapy, Lung Diseases, Parasitic / complications / drug therapy / parasitology, Lymphoma, Follicular / drug therapy / surgery, Male, Middle Aged, Postoperative Complications / etiology, Pulmonary Alveoli / parasitology / pathology, Sepsis / complications / drug therapy, Shock, Septic / etiology, Strongyloides stercoralis, Strongyloidiasis / complications / drug therapy, Thiabendazole / therapeutic use
Abstract

BACKGROUND: Hematopoietic stem cell transplantation is being increasingly used in cancer therapy. Diffuse alveolar hemorrhage, an early complication of stem cell transplant, results from bacterial, viral and fungal infections, coagulopathy, and engraftment syndrome, or can be idiopathic. Diffuse alveolar hemorrhage associated with Strongyloides stercoralis hyperinfection in stem cell transplant patients has been rarely reported. CASE PRESENTATION: We describe an unusual cause of alveolar hemorrhage post hematopoietic stem cell transplant due to Strongyloides hyperinfection. Therapy with parenteral ivermectin and thiabendazole was initiated but the patient deteriorated and died of respiratory failure and septic shock. CONCLUSION: Strongyloides stercoralis hyperinfection is an unusual cause of alveolar hemorrhage early after hematopoietic stem cell transplant with very high mortality.

DOI10.1186/1471-2407-6-87
Alternate JournalBMC Cancer
Notify Library Reference ID1711

Related Incidents